CASRAI Dictionary

Tag: grant peer review

  • Peer Review of Grant Proposals Under Political Pressure: The Case for Independence

    A funding notice should be a statement of scientific priority, not a political signal. Yet across 2025 and into 2026, the machinery that has historically separated the two — peer review grant proposals through panels of independent subject-matter experts — has come under direct pressure from proposals that would let political appointees override merit-based funding recommendations. This is an argument, not a survey: politicised screening of grant notices does not just change who gets funded, it erodes the evidentiary basis on which the public is asked to trust science at all.

    Why Independent Peer Review Underpins Public Trust

    Grant peer review exists to answer one narrow question: is this proposal, on scientific merit, worth public money? Reviewers assess feasibility, methodological rigour, and the track record of the team, insulated as far as possible from who is asking or why. UK Research and Innovation’s guidance for its research councils is explicit about this insulation: proposals go to at least three independent reviewers, comments are handled in confidence, and funders are told not to substitute journal-based metrics or reputation for direct scientific judgement, in line with the San Francisco Declaration on Research Assessment (DORA).

    That model works because it is boring by design. Merit review is meant to be the least newsworthy part of the research funding cycle — a quiet, expert, reproducible filter. When it becomes contested political territory, the filter itself becomes a variable, and every downstream claim about “the best science being funded” loses its footing.

    The 2026 Pressure Points: Political Override and Funding Cuts

    Two developments in the United States illustrate the risk. First, a proposed rule from the White House Office of Management and Budget would give political appointees at federal agencies final authority over grant funding decisions, including the ability to terminate active awards that no longer align with stated “agency priorities” or the “national interest” — language broad enough to reach almost any politically contested field, from climate science to public health. Second, budget proposals affecting the National Institutes of Health and National Science Foundation, alongside a reported NIH plan to consolidate its institutes and centres and restructure study-section peer review, have combined to shrink the pool of fundable awards even as application volume holds steady or rises.

    Neither development is hypothetical process detail. Together they change what a grant notice signals: not “this call is open to the best proposal” but “this call is open to the best proposal that also survives a discretionary political filter after review.” The Association of American Universities and multiple scientific societies have flagged this combination as a structural threat to the research enterprise, not a routine administrative reform.

    The comparison with the UK’s model is instructive, not because either system is beyond criticism, but because it shows what an evidentiary firewall between political priority-setting and technical merit assessment actually looks like in practice:

    Safeguard UKRI research council practice US 2026 OMB proposal risk
    Reviewer independence Minimum three reviewers, including one nominated by the applicant Political appointees can override expert panel recommendations
    Confidentiality Proposals handled “in confidence”; reviewer identities protected until decision No published equivalent confidentiality standard cited in the proposal
    Assessment criteria DORA-aligned; journal metrics and reputation explicitly excluded Alignment with “agency priorities” or “national interest” is an added, non-scientific criterion
    Award stability Funded projects proceed on scientific timelines set at award Active awards may be terminated mid-project if priorities shift

    Common Questions on Grant Peer Review

    What are peer-reviewed grants?

    Peer-reviewed grants are awards where an independent panel of subject-matter experts assesses a proposal’s scientific merit, feasibility, and rigour before funds are released. Agencies including NIH, UKRI, and most major foundations use this process to allocate limited public or philanthropic funding to the strongest available science, rather than by administrative discretion alone.

    What is the golden rule of peer review?

    The golden rule of peer review is to judge the work on its merits, free of conflicts of interest or external pressure. Reviewers assess methodology, evidence, and feasibility rather than the identity, politics, or institutional profile of the applicant — the same principle that underlies publication peer review under bodies such as COPE and ICMJE.

    What are the key elements of grant peer review?

    Core elements include reviewer expertise, documented conflict-of-interest management, confidentiality of unpublished ideas, structured and consistent scoring criteria, and a documented decision trail. Removing any one element — for example, by inserting a discretionary political override after panel scoring — weakens the evidentiary chain the whole process is meant to produce.

    What Politicised Review Does to the Evidence Base

    Research administrators should treat this as an evidentiary problem before it is a funding problem. If a funding decision can be overridden on non-scientific grounds after expert review, the review itself stops functioning as reliable evidence of merit — for auditors, for future meta-research, and for the public record. That has knock-on effects:

    • Grant history becomes an unreliable signal for institutional research assessment and future funder due diligence.
    • Researchers in politically sensitive fields face a de facto chilling effect, shaping what gets proposed long before any panel convenes.
    • Cross-border collaborations and co-funding arrangements, for example with Horizon Europe partners, become harder to underwrite if one partner’s award pipeline is subject to discretionary termination.
    • Standardised, interoperable research-administration infrastructure — persistent identifiers, contributor role taxonomies, funder metadata — loses value if the funding decisions it documents are not reliably merit-based.

    Forward Look: How Institutions Can Preserve Merit Review

    Research offices and institutional leaders are not bystanders here. Several concrete, defensible steps can preserve the evidentiary integrity of merit review even where political pressure on funders intensifies:

    • Document review outcomes independently. Retain institutional records of panel scores and reviewer comments separate from final award notices, so a political override is auditable rather than silent.
    • Diversify funding portfolios. Reduce single-funder dependency so that one agency’s discretionary process does not determine an entire research programme’s viability.
    • Support reviewer capacity. Volunteer reviewing is already strained by rising application volumes; institutions that credit peer-review service in promotion and workload models help sustain the expert pool the whole system depends on.
    • Use standardised, verifiable metadata. Persistent identifiers and transparent contribution records make it harder to quietly substitute political criteria for merit criteria after the fact, and easier for auditors and journalists to reconstruct what actually happened.

    None of this substitutes for the underlying policy fight over whether political appointees should hold override authority at all. But it is what research administration can control while that fight plays out — and it rests on the same logic as standardised, verifiable contribution frameworks such as CRediT, which CASRAI originated in 2014 as an interoperable way to document who did what on a piece of research; the standard is now stewarded by NISO as ANSI/NISO Z39.104-2022. Merit-based science depends on infrastructure that makes evidence, including evidence of how funding decisions were actually made, auditable rather than assumed.

  • Grant Peer Review Under OMB’s Proposed 2026 Uniform Grants Regulation

    The Office of Management and Budget (OMB) has proposed a rewrite of the federal government’s grant-making rulebook that would change how grant peer review functions across agencies including the National Institutes of Health (NIH), the National Science Foundation (NSF) and the Department of Energy. According to reporting from STAT News, Inside Higher Ed, Science and NPR, the draft rule would convert the long-standing “Uniform Guidance” (2 CFR Part 200) into a binding “Uniform Grants Regulation,” subordinating scientific merit review to a new layer of political sign-off and giving agency political appointees explicit authority to terminate awards that no longer track administration priorities.

    For research administrators, the proposal is not a routine compliance update. It touches the mechanism — independent expert review — that has underpinned federal research funding decisions for more than half a century.

    What OMB’s Proposed Grants Rule Changes

    Uniform Guidance governs financial assistance rules across virtually every federal grant-making agency, covering everything from allowable costs to audit requirements. OMB’s proposal would elevate that guidance to a binding regulation and layer several new mechanisms on top of it. The core changes reported by STAT, Inside Higher Ed, Science and NPR include:

    • A mandatory pre-issuance review of discretionary grant awards by senior political appointees before funds are released.
    • Reclassification of peer-review recommendations as advisory rather than binding or routinely deferred to.
    • An undefined “Gold Standard Science” criterion appointees may apply during sign-off.
    • Expanded termination authority for awards deemed misaligned with agency priorities, including multi-year awards already underway.
    • New pre-approval requirements for costs tied to publications, conference attendance and journal subscriptions.
    • A “domestic-first” preference framework for research and development awards.
    • Prohibitions on funding tied to diversity, equity and inclusion (DEI) activities, “gender ideology,” or research supporting disparate-impact liability theories.
    • Elimination of fixed-amount subawards.

    The public comment period is reported to close on 13 July 2026, with an anticipated effective date of 1 October 2026 if the rule is finalised largely as proposed.

    From Deference to “Advisory”: How Peer Review’s Role Shrinks

    Under current practice, agencies such as NIH route applications through scientific review groups or study sections, which score proposals on significance, approach, innovation and investigator qualifications. Program officials retain formal award authority, but in practice they defer heavily to review scores and percentile rankings to set paylines.

    The proposed rule text, as reported across multiple outlets, states that peer-review recommendations “are not ministerially ratified, routinely deferred to, or otherwise treated as de facto binding” by senior appointees. That is a structural change: a proposal that clears scientific review with a strong score could still be delayed, reprioritised or rejected at a political pre-issuance gate that sits above the merit-review process rather than alongside it.

    Research associations — including the Association of Public and Land-grant Universities (APLU), the American Association for Cancer Research (AACR) and the Computing Research Association (CRA) — have raised concerns that the change would insert non-scientific criteria into funding decisions that have historically been insulated from politics precisely to protect scientific rigour and public trust.

    Aspect Current practice Proposed rule
    Peer-review status De facto determinative for most competitive awards Explicitly advisory
    Final sign-off Program/agency officials, largely deferential to review scores Senior political appointees, mandatory pre-issuance review
    Termination grounds Non-compliance, budget, performance Adds “no longer aligned with agency priorities,” including mid-award
    Allowable costs Publications, conferences, subscriptions generally allowable Pre-approval required for these cost categories
    Subaward mechanism Fixed-amount subawards permitted Fixed-amount subawards eliminated

    Grant Peer Review: Common Questions Answered

    What is a peer-reviewed grant?

    A peer-reviewed grant is funding awarded after independent subject-matter experts assess a proposal’s scientific merit — its significance, approach, feasibility and investigator qualifications — typically through a scored study section or review panel. At NIH, review groups assign priority scores that traditionally shape funding decisions, though final award authority sits with the agency, not the reviewers.

    What is the peer review process for grant applications?

    The peer review process for grant applications routes each proposal to subject-matter reviewers, who score it against published criteria and then discuss and rank applications in a panel meeting. Agencies use these rankings to set paylines and prioritise funding. Under OMB’s proposed rule, that ranking becomes one advisory input rather than the determining factor in a funding decision.

    Do grant reviewers get paid?

    Yes. Federal agencies, including NIH, typically pay peer reviewers a daily honorarium plus travel expenses for study section service. Many reviewers describe the compensation as modest relative to the time required to read, score and discuss a full panel’s worth of competing applications ahead of each review cycle.

    Expanded Termination Authority and Award-Level Risk

    Beyond the review gate itself, the proposal reported by STAT, Science and Inside Higher Ed would broaden agencies’ authority to suspend or terminate grants — including multi-year awards already in progress — if they are deemed no longer aligned with agency priorities or the “national interest.” It would also widen risk assessment of applicants to consider an institution’s affiliation with organisations engaged in activities that “violate Federal law, undermine public safety or national security, or advocate for the overthrow of the United States Government,” a standard with considerable interpretive latitude.

    Paired with new pre-approval requirements for publication, conference and journal-subscription costs, and the removal of fixed-amount subawards, the combined effect is a research-funding environment where mid-project risk is materially higher than under the current framework, even for awards that passed scientific review cleanly.

    What This Means for Research Administrators

    For institutions managing portfolios that depend on merit-reviewed research funding, the proposal raises operational, not just scientific, questions. Recommended near-term actions include:

    • Model termination risk explicitly in multi-year budget and staffing plans, rather than treating a scored, funded award as a settled commitment.
    • Audit cost-approval workflows for publication, conference and subscription spending now, ahead of any pre-approval mandate taking effect.
    • Brief principal investigators on the distinction between a favourable peer-review score and a final funding decision under the proposed pre-issuance review.
    • Coordinate institutional comments through professional associations such as NCURA and ARMA before the docket closes.
    • Track subaward structures that rely on fixed-amount mechanisms, which the proposal would eliminate.

    Offices that have historically treated peer-review outcomes as the primary predictor of award stability will need a second, policy-alignment layer in their risk assessment — one that is harder to forecast because it depends on political judgement rather than published scoring criteria.

    What Happens Next

    The proposed rule remains open for public comment, with reporting placing the deadline at 13 July 2026 and a possible effective date of 1 October 2026 if OMB finalises it substantially as drafted. Scientific and higher-education associations are expected to submit extensive comments opposing the advisory reclassification of peer review, and legal challenges are plausible if the rule is finalised without significant revision, given its scope relative to existing statutory peer-review requirements at agencies such as NIH.

    Until the final text is published, research administrators should treat every provision summarised here as subject to change — but the direction of travel is unambiguous: less deference to scientific merit review, and more discretionary authority at the award-decision and award-termination stages. Institutions that update their risk models and compliance workflows now will be better placed to respond once the rule, in whatever form it takes, becomes binding.